Literature DB >> 2783946

Promotion of human T lymphocyte proliferation by IL-4.

L C Mitchell1, L S Davis, P E Lipsky.   

Abstract

The capacity of human rIL-4 to support the proliferation of mitogen-stimulated T cells directly as well as by increasing IL-2 production or enhancing IL-2 responsiveness was investigated. IL-4 augmented proliferation of T cells stimulated with PHA, Con A, immobilized mAb to the CD3 molecular complex (OKT3), or PMA. IL-4 increased the number of mitogen-stimulated cells entering the cell cycle as well as enhancing ongoing proliferation of mitogen-activated lymphoblasts. Facilitation of initial activation by IL-4 was not inhibited by mAb to the p55 component of the IL-2R, anti-Tac, and, therefore, was not dependent on endogenous IL-2 activity. However, IL-4-mediated enhancement of ongoing T cell proliferation stimulated by PHA or OKT3 was partially but not completely blocked by anti-Tac. Analysis of the supernatants from PHA-stimulated T cell cultures indicated that IL-4 increased the production of IL-2 by mitogen-activated cells. Moreover, IL-4 increased the amount of IL-2 mRNA that accumulated in mitogen-stimulated T cells. In addition, IL-4 markedly augmented IL-2R expression by PHA-stimulated T cells. Although IL-4 promoted ongoing DNA synthesis of mitogen-stimulated T cells in an IL-2-dependent manner, it was also able to sustain their proliferation directly. Thus, IL-4 supported proliferation of PMA-activated T cells in a manner that was not inhibited by anti-Tac. Furthermore, IL-4 could augment proliferation and IL-2R expression of T cells stimulated with PHA in the presence of cyclosporin A, which blocks endogenous cytokine production or anti-Tac. Finally, IL-4 was noted to enhance proliferation of both CD4+ and CD8+ T cell subsets. The results indicate that IL-4 enhances proliferation of mitogen-activated human T cells by a number of mechanisms, including the direct promotion of cell cycle entry and subsequent DNA synthesis, enhanced production of IL-2, and increased responsiveness to IL-2 in part by up-regulation of IL-2R expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783946

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Human CD4+ T cell differentiation and effector function: implications for autoimmunity.

Authors:  L S Davis; H Schulze-Koops; P E Lipsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes.

Authors:  J B Splawski; P E Lipsky
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 3.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

4.  Cell-cell interactions for CD23 expression and soluble CD23 release from peripheral lymphocytes of atopic donors.

Authors:  K Kicza; A Fischer; T Pfeil; J Bujanowski-Weber; W König
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

5.  Involvement of the interleukin 4 pathway in the generation of functional gamma delta T cells from human pro-T cells.

Authors:  A Bárcena; M J Sánchez; J L de la Pompa; M L Toribio; G Kroemer; C Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin.

Authors:  H Luo; H Chen; P Daloze; G St-Louis; J Wu
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

7.  Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.

Authors:  K Kurokohchi; T Akatsuka; C D Pendleton; A Takamizawa; M Nishioka; M Battegay; S M Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical model.

Authors:  B F Morel; M A Burke; J Kalagnanam; S A McCarthy; D J Tweardy; P A Morel
Journal:  Bull Math Biol       Date:  1996-05       Impact factor: 1.758

9.  Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HIV-1) infection.

Authors:  R Zambello; L Trentin; R Benetti; A Cipriani; C Crivellaro; P Cadrobbi; C Agostini; G Semenzato
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

10.  Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.

Authors:  P T Soboslay; C M Dreweck; W H Hoffmann; C G Lüder; C Heuschkel; H Görgen; M Banla; H Schulz-Key
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.